Sale!

SLC20A2 Gene Basal Ganglia Calcification Type 1 Ideopathic Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC20A2 gene is closely associated with Primary Familial Brain Calcification (PFBC), also known as Basal Ganglia Calcification Type 1. This condition is characterized by the accumulation of calcium deposits in the brain, particularly in the basal ganglia, which can lead to a variety of neurological symptoms including movement disorders, psychiatric symptoms, and cognitive impairment. The condition is hereditary, following an autosomal dominant pattern of inheritance, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.

The genetic test for identifying mutations in the SLC20A2 gene is crucial for diagnosing PFBC. It helps in confirming the diagnosis, understanding the risk of transmission to offspring, and aiding in the management and treatment of the condition. This test involves analyzing the DNA to look for mutations in the SLC20A2 gene that are known to cause the condition.

In the UAE, DNA Labs offers this specialized genetic test. The cost of the test is set at 4400 AED. DNA Labs UAE is equipped with advanced genetic testing facilities to provide accurate and reliable results. The test is performed under the guidance of genetic experts and is aimed at individuals who have a family history of PFBC or exhibit symptoms suggestive of basal ganglia calcification.

By opting for this test, individuals can gain valuable insights into their genetic makeup, enabling them and their healthcare providers to make informed decisions regarding their health and management of the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC20A2 Gene Basal Ganglia Calcification Type 1 Ideopathic Genetic Test

At DNA Labs UAE, we offer the SLC20A2 Gene Basal Ganglia Calcification Type 1 Ideopathic Genetic Test. This test is designed to analyze the SLC20A2 gene, which is associated with a rare genetic disorder known as basal ganglia calcification type 1 or idiopathic basal ganglia calcification (IBGC).

Basal ganglia calcification is characterized by the abnormal buildup of calcium deposits in the brain, specifically in the basal ganglia region. Our NGS (Next-Generation Sequencing) technology allows for the simultaneous analysis of multiple genes, making it a powerful tool for identifying variations or mutations in the SLC20A2 gene that may be responsible for basal ganglia calcification type 1.

By analyzing the DNA sequence of the SLC20A2 gene, our NGS genetic testing can help diagnose basal ganglia calcification type 1 and provide valuable information about the specific genetic mutation causing the condition. This information can be useful for understanding the inheritance pattern of the disease, predicting the likelihood of passing it on to future generations, and potentially guiding treatment decisions.

Test Details

Test Name: SLC20A2 Gene Basal Ganglia Calcification Type 1 Ideopathic Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information

Prior to undergoing the SLC20A2 Gene Basal Ganglia Calcification Type 1 Ideopathic Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with SLC20A2 Gene Basal Ganglia Calcification Type 1.

A genetic counselor can provide more specific information about the test, its benefits, limitations, and potential implications for individuals and their families. It is important to consult with a healthcare professional or a genetic counselor to discuss the appropriateness and availability of NGS genetic testing for basal ganglia calcification type 1.

For more information about our SLC20A2 Gene Basal Ganglia Calcification Type 1 Ideopathic Genetic Test, please contact DNA Labs UAE.

Test Name SLC20A2 Gene Basal ganglia calcification type 1 ideopathic Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC20A2 Gene Basal ganglia calcification type 1, ideopathic NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC20A2 Gene Basal ganglia calcification type 1, ideopathic NGS Genetic DNA Test gene SLC20A2
Test Details

The SLC20A2 gene is associated with a condition called basal ganglia calcification type 1, also known as idiopathic basal ganglia calcification (IBGC). Basal ganglia calcification is a rare genetic disorder characterized by the abnormal buildup of calcium deposits in the brain, specifically in the basal ganglia region.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes. It is a powerful tool that can identify variations or mutations in the SLC20A2 gene, which may be responsible for basal ganglia calcification type 1.

By analyzing the DNA sequence of the SLC20A2 gene, NGS genetic testing can help diagnose basal ganglia calcification type 1 and provide valuable information about the specific genetic mutation causing the condition. This information can be useful for understanding the inheritance pattern of the disease, predicting the likelihood of passing it on to future generations, and potentially guiding treatment decisions.

It is important to consult with a healthcare professional or a genetic counselor to discuss the appropriateness and availability of NGS genetic testing for basal ganglia calcification type 1. They can provide more specific information about the test, its benefits, limitations, and potential implications for individuals and their families.